Advanced Research and Diagnostic Laboratory (ARDL)
A central biochemistry laboratory
The Advanced Research and Diagnostic Laboratory (ARDL) provides the latest technology and clinical laboratory testing services to researchers and other customers via a 16,000-square-foot customized facility.
Constructed in 2013, the ARDL facility is recognized worldwide as a front-runner in innovative design and operational excellence.
High-Volume Immunoassay Testing Platforms
- Specimen collection / processing
- Specimen testing and analysis
- Quality control / assurance
- Specimen storage
Mass Spectrometer Center
- Sample analysis
- Quantitative proteomics
- Assay development
- Assay validation
- Long-term sample storage
- Cell cryopreservation
- DNA sample storage
- Power back-up protection
ARDL is fully accredited as a highly complex laboratory by the Clinical Laboratory Improvement Act (CLIA), the College of American Pathologists (CAP), and the New York State Department of Health. High standards such as these are considered a starting point for ARDL, and a basis for a level of quality unsurpassed in the industry.
ARDL was named Central Biochemistry Laboratory (CBL) for CDC's National Health and Nutrition Examination Survey (NHANES) in September. NHAES is a CDC program designed to assess the health and nutritional status of adults and children in the U.S. The survey examines a nationally representative sample of about 5,000 individuals each year. Findings from the survey will be used to determine the prevalence of major diseases and risk factors for diseases. ARDL director Anthony Killeen is the CBL principal investigator for the 5-year program.
SPRINT Study mentioned 06/22/2015
Hispanic Community Health Study / Study of Latinos (HCHS/SOL) covered 06/24/2015